3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rhabdoid Tumor
3
Pinealoma
3
Neuroectodermal Tumors, Primitive
3
Neoplasms, Germ Cell and Embryonal
3
Medulloblastoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Glioma
3
Ependymoma
3
Choroid Plexus Carcinoma
3
Central Nervous System Neoplasms
3
Brain Neoplasms
3
Lymphoma, Follicular
2
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Diffuse Intrinsic Pontine Glioma
1
Dendritic Cell Sarcoma, Interdigitating
1
CD7-Positive Hematological Malignancies
1
Burkitt Lymphoma
1
Interventions
pembrolizumab
12
Pemetrexed
9
Cisplatin
9
Nivolumab
8
Carboplatin
8
Ipilimumab
7
Cyclophosphamide
6
fludarabine
5
durvalumab
4
tremelimumab
2
Radiotherapy, Intensity-Modulated
2
Gemcitabine
2
Cerebral Decortication
2
tocilizumab
1
tislelizumab
1
tazemetostat
1
sotorasib
1
ruxolitinib
1
osimertinib
1
olaparib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
bintrafusp alfa protein, human
1
avelumab
1
atezolizumab
1
Tumor Burden
1
Tablets
1
Saline Solution
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
Automobiles
×
1 year
×
Clear all
No trials found.